Attached files
file | filename |
---|---|
EX-23.1 - EX-23.1 - Vincerx Pharma, Inc. | d117132dex231.htm |
EX-10.3 - EX-10.3 - Vincerx Pharma, Inc. | d117132dex103.htm |
EX-10.2 - EX-10.2 - Vincerx Pharma, Inc. | d117132dex102.htm |
EX-10.1 - EX-10.1 - Vincerx Pharma, Inc. | d117132dex101.htm |
EX-5.1 - EX-5.1 - Vincerx Pharma, Inc. | d117132dex51.htm |
EX-4.2 - EX-4.2 - Vincerx Pharma, Inc. | d117132dex42.htm |
EX-4.1 - EX-4.1 - Vincerx Pharma, Inc. | d117132dex41.htm |
EX-3.1 - EX-3.1 - Vincerx Pharma, Inc. | d117132dex31.htm |
S-1 - S-1 - Vincerx Pharma, Inc. | d117132ds1.htm |
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We hereby consent to the use in the Prospectus constituting a part of this Registration Statement on Form S-1 of our report dated September 22, 2020 relating to the financial statements of LifeSci Acquisition Corp., which is contained in that Prospectus. We also consent to the reference to us under the caption Experts in the Prospectus.
/s/ WithumSmith+Brown, PC
January 29, 2021